Medtronic Receives FDA Approval For Expanded MRI Labeling On Percept PC, Percept RC, And Activa PC, RC, SC Devices
Portfolio Pulse from Benzinga Newsdesk
Medtronic has received FDA approval for expanded MRI labeling on its Percept PC, Percept RC, and Activa PC, RC, SC devices. This approval allows for broader MRI access for patients using these devices.
August 21, 2024 | 5:54 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Medtronic has received FDA approval for expanded MRI labeling on its Percept and Activa devices, which could lead to increased adoption and usage of these devices.
The FDA approval for expanded MRI labeling is significant as it allows more patients to safely undergo MRI scans with Medtronic's devices, potentially increasing the devices' market appeal and usage. This regulatory milestone is likely to positively impact Medtronic's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100